Songjiang Ma
President · GYRE THERAPEUTICS, INC.
- 2024
- May 27, 2025
- 10
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Songjiang Ma files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Songjiang Ma?
Songjiang Ma is a corporate insider, tracked as President of GYRE THERAPEUTICS, INC. (GYRE). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Songjiang Ma last file a Form 4?
The most recent primary Form 4 on record is dated 27 May 2025, one of 10 filings going back to 2024.
Has Songjiang Ma been buying or selling stock?
Recorded transactions: 0 open-market purchases and 24 open-market sales ($392K) across all tracked filings.
